Tiny antibody component highly effective against SARS-COV-2 in animal studies

Scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug — known as Ab8 — for potential use as a therapeutic and prophylactic against SARS-CoV-2.

Leave a Reply

Your email address will not be published. Required fields are marked *